Sens. Kirsten Gillibrand (D-N.Y.), Kamala Harris (D-Calif.), and Amy Klobuchar (D-Minn.), who each are seeking the 2020 Democratic nomination for president, have announced separate plans to address high prescription drug costs in the United States.

CMS on Thursday released a proposed rule to update certain Medicare payment regulations under the Home Health Prospective Payment System and increase payments for home health agencies by 1.3%.

A federal appeals court on Thursday denied a request for an emergency stay on a recent ruling that allows HHS' final rule to bar health care providers and clinics that receive Title X family planning grants from providing or referring patients for abortion care.

CMS on Wednesday issued a proposed rule to implement a mandatory bundled payment model intended to replace Medicare's current fee-for-service payment model for radiation oncology in certain geographic regions.

CMS on Thursday issued a proposed rule that would eliminate existing requirements on how states assess access to care among fee-for-service (FFS) Medicaid beneficiaries and replace them with a more standardized approach that the agency hopes to develop with industry stakeholders.

HHS on Tuesday announced that the department is launching a Quality Summit that aims to bring together government officials and health care industry stakeholders to discuss how HHS quality programs should be evaluated, adapted, and streamlined to help promote value-based care and bolster patient outcomes.

Adam Boehler will step down as director and deputy administrator of CMS' Center for Medicare and Medicaid Innovation, after President Trump on Wednesday nominated Boehler to oversee the U.S. International Development Finance Corporation.

The Trump administration has withdrawn its proposed rule to prohibit drugmakers from paying rebates to pharmacy benefit managers under federal health programs, a White House spokesperson confirmed Wednesday.

President Trump on Wednesday issued an executive order that calls on HHS to overhaul the kidney care and donation allocation process, and HHS shortly after unveiled new payment models for Medicare providers who manage patients with kidney disease and end-stage renal disease.

Health inspectors from 2012 through 2016 cited nearly 90% of hospices for at least one deficiency—and about 20% of hospices had deficiencies serious enough to put patients in danger, according to a pair of reports released Tuesday by the HHS' Office of the Inspector General.